CalcMyPeptide

GLP-1 Dose Escalation Scheduler

GLP-1 receptor agonists require gradual dose escalation to minimize gastrointestinal side effects. Select your medication below and enter your start date to generate a complete week-by-week schedule with injection dates and syringe units.

GLP-1 Dosplanerare

GLP-1 RA · Once weekly

Din Nuvarande VeckaMonth 1

0.25mg

Vecka 1 · Wegovy

V 1

av 20

Nästa upptrappning: 0.5 mg in 4 veckor (Vecka 5)

Upptrappningstidslinje

0.25 mg
0.5 mg
1 mg
1.7 mg
2.4 mg
V 1V 20
VDatumDos
13/23/20260.25 mgDU
23/30/20260.25 mg
34/6/20260.25 mg
44/13/20260.25 mg
54/20/20260.5 mg
64/27/20260.5 mg
75/4/20260.5 mg
85/11/20260.5 mg
95/18/20261 mg
105/25/20261 mg
116/1/20261 mg
126/8/20261 mg
136/15/20261.7 mg
146/22/20261.7 mg
156/29/20261.7 mg
167/6/20261.7 mg
177/13/20262.4 mg
187/20/20262.4 mg
197/27/20262.4 mg
208/3/20262.4 mg

Källa: FDA Label (Wegovy) / STEP 1 Trial · Viktminskning: ~15% · t½: ~7 dagar

Supported Protocols

Semaglutide (Wegovy)

GLP-1 Agonist

0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg

Source: FDA Label

Semaglutide (Ozempic)

GLP-1 Agonist

0.25 → 0.5 → 1.0 mg

Source: FDA Label

Tirzepatide (Mounjaro)

Dual GIP/GLP-1

2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg

Source: FDA Label

Retatrutide (Phase II)

Triple Agonist

1 → 2 → 4 → 8 → 12 mg

Source: PMID: 37351564

Explore the Compounds

Dive into detailed profiles covering mechanism of action, clinical trial data, and dosing calculations.

Related Tools